Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Stock market hammered despite upbeat data

Published 04/30/2015, 06:03 PM
Updated 04/30/2015, 06:03 PM
© Reuters. Traders work on the floor of the New York Stock Exchange

By Caroline Valetkevitch

(Reuters) - U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.

Upbeat economic reports added to uncertainty about the outlook for interest rates, a day after data showed the U.S. economy had slowed to a crawl in the first quarter and the Federal Reserve pointed to weakness in the labor market and other areas of the U.S. economy.

Despite the day's decline, all three major indexes posted slight gains for April.

The Nasdaq biotech index (NBI) dropped 3.1 percent on Thursday, led by a 4.5 percent fall in Celgene (O:CELG), which reported lower-than-expected quarterly revenue.

The decline marked a fifth day of losses for the biotech index, which was down 8.1 percent for the week so far.

The Nasdaq fell for a fourth straight day, and was off 3 percent from Friday's record closing high. The S&P tech index <.SPLRCT> slid 1.6 percent, the day's worst-performing sector, while small-cap stocks also underperformed. The Russell 2000 small-cap index <.RUT> was down 2.2 percent.

Apple (O:AAPL), down 2.7 percent at $125.15, was the biggest drag on the three major indexes. The company limited the availability of the Apple Watch after a key component was found to be defective, according to the Wall Street Journal.

"Biotechs and tech were leaders and now they've reversed," said Peter Cardillo, chief market economist at Rockwell Global Capital in New York.

"Earnings don't really support the valuations at this time, and I think the market needs to correct a bit. As we go into May I would say the best prescription would be to sell in May and go away."

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The Dow Jones industrial average (DJI) fell 195.01 points, or 1.08 percent, to 17,840.52, the S&P 500 (SPX) lost 21.34 points, or 1.01 percent, to 2,085.51 and the Nasdaq Composite (IXIC) dropped 82.22 points, or 1.64 percent, to 4,941.42.

For the month, the Dow was up 0.4 percent, the S&P 500 gained 0.9 percent and the Nasdaq rose 0.8 percent.

The day's data included a report showing the number of Americans filing new claims for unemployment benefits tumbled to a 15-year low last week.

After the bell, LinkedIn (N:LNKD) shares fell 24 percent to $191.70 and Gilead (O:GILD) shares gained 3.2 percent to $103.69 following the release of results. First Solar (O:FSLR) and SunPower (O:SPWR) both declined after hours following results.

During the regular session, Baidu (O:BIDU) declined 8.5 percent to $200.28 after China's dominant Internet search engine provider reported its slowest quarterly revenue growth rate in almost seven years.

S&P 500 earnings for the first quarter now are expected to have risen 1.1 percent, Thomson Reuters data showed, while revenue was expected to be down 3.2 percent.

Declining issues outnumbered advancing ones on the NYSE by 2,355 to 693; on the Nasdaq, 2,131 issues fell and 647 advanced. About 8.5 billion shares changed hands on U.S. exchanges, compared with the 6.3 billion daily average for the month to date, according to BATS Global Markets.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.